Challenges in Drug Manufacturing and Concerns with Compound Pharmacies

4min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter explores the obstacles faced in producing medications like Ozempic and the role of compound pharmacies in supplying drugs during shortages. It also raises awareness about the risks associated with receiving medications from such pharmacies, emphasizing the need for prescription verification and pharmacy legitimacy checks.

There's been a surge in discourse around medications such as Ozempic, prompting understandable skepticism—Is this another weight loss fad, or the beginning of something new? While it is primarily used to treat diabetes and promote weight loss, there's mounting evidence that shows drugs like Ozempic can reduce the risk of heart attacks and strokes, and potentially be instrumental in treating addiction. In this episode, Adam speaks with Dr. Dhruv Khullar, a physician and assistant professor of health policy and economics at Weill Cornell Medical College, exploring the efficacy, risks, and impact these drugs have on our relationship with weight and food.

SUPPORT THE SHOW ON PATREON: https://www.patreon.com/adamconover

SEE ADAM ON TOUR: https://www.adamconover.net/tourdates/

SUBSCRIBE to and RATE Factually! on:

» Apple Podcasts: https://podcasts.apple.com/us/podcast/factually-with-adam-conover/id1463460577

» Spotify: https://open.spotify.com/show/0fK8WJw4ffMc2NWydBlDyJ

About Headgum: Headgum is an LA & NY-based podcast network creating premium podcasts with the funniest, most engaging voices in comedy to achieve one goal: Making our audience and ourselves laugh. Listen to our shows at https://www.headgum.com.

» SUBSCRIBE to Headgum: https://www.youtube.com/c/HeadGum?sub_confirmation=1

» FOLLOW us on Twitter: http://twitter.com/headgum

» FOLLOW us on Instagram: https://instagram.com/headgum/

» FOLLOW us on TikTok: https://www.tiktok.com/@headgum

» Advertise on Factually! via Gumball.fm

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.